Caci has strengthened its commitment to clinical excellence with the appointment of two
highly respected industry leaders to its Clinical Advisory Board, reinforcing the standards of safety, governance and innovation across its network of 75+ clinics nationwide.
Joining the board are John Boy Jerry Csapo-Camu and Bradley Csapo-Camu, who will work alongside existing board members Brandy Wehinger, Dr Charlotte Auty, Mr Julian Lofts, and Dr Michelle Locke.
For more than 30 years, Caci has led New Zealand’s skincare and appearance industry, with its multidisciplinary Clinical Advisory Board playing a critical role in maintaining the highest standards of customer care, safety and best practice for the past 25 years.
John Boy Jerry Csapo-Camu, nurse practitioner and clinic owner, has been appointed
Clinical Director of Governance and Safety. With more than 20 years of experience spanning acute care, urgent care, general practice, infection control, aesthetics, clinical governance and nurse leadership, John will lead the continued evolution of Caci’s governance frameworks, patient safety standards, risk management and quality improvement initiatives.
Bradley Csapo-Camu joins as Clinical Director of Development and Innovation. A clinic
owner and nurse with a diverse clinical and commercial background, Bradley brings a
powerful combination of leadership, regulatory expertise and business acumen. He is also a board member of the Clinical Aesthetics Network of New Zealand (CANNZ), which
advocates for patient safety and professional excellence across the aesthetics sector.
Jackie Smith, founder of Caci, says the appointments reflect Caci’s ongoing commitment to setting the benchmark for safe, ethical and results-driven care.
“Clinical excellence and strong governance are central to everything we do at Caci. We are
thrilled to welcome John and Bradley to the Clinical Advisory Board.
They are exceptional practitioners with deep clinical expertise and an unwavering
commitment to improving healthcare outcomes in New Zealand. Their leadership will further strengthen the robust governance and best-practice standards that underpin every Caci treatment nationwide.”
The Caci Clinical Advisory Board serves as the clinical governance body for the business,
providing expert oversight to ensure safe, consistent, high-quality treatment delivery across all clinics. Drawing on expertise from registered nurses, medical professionals and skin therapists, the board shapes clinical protocols, education, treatment standards and safety compliance.
This includes evaluating emerging cosmetic injectable and skin treatments against rigorous safety criteria, overseeing the ongoing training and professional development of Caci’s nurses and skin therapists, and guiding the protocols behind personalised Caci Membership treatment plans to help ensure consistently high standards and visible results across New Zealand.
Caci strengthens clinical governance with two new advisory board appointments
